1、? 3 qr33%,*? 3 q25%,0W - ? 3 q13%, q88%, q20%。N,UAE T ? 395。UAE ( Y V ? 5 , 0 ?。yN, “ - 4 (UAE 1 0。UAE V ? x 0 = 7。1 4YV0 x x5 xh * 。UAE x ?Y V ? M -1, M - vC q,7UAE M ? x ?Yv。y /:(1)M -v o x! ?/, 4 。(2)M -v o x /, 4 VF 。(3) , Bs PUAE9| 。Ahmad1432 26 45 ( (34 ) oUAE x ? N,?CUAE -# 3 x O (FSH)sY(6.83
2、 1.80)IU/L(6.991.67)IU/L,MAil, (2 3。2 o FSHsYV22IU/L30IU/L 640IU/L48IU/L,iC 。V “ -UAE 0 ? A,UAE ? e rT z, B L。 “5 UAE1 a ? m 、m 31 p ?。N/ ?、* / ? 8 /4、 4V 9 aUAE 。 40 1; xM* ? 3 V ?,1 b SD =h 4、 i? ) 、 m Z 1 SD = MT15。9,1 4 a,gB V9 m 0 n 。 ID1 RavinaJH, HerbreteauD, Ciraru-Vigneron, etal.Arterialem-
3、bolisationtotreatuterinemyomataJ.Lancet, 1995, 346:671-672.2 = , g +, ,.0 0 ?42 “5sJ. S, 2002, 37(1):8-11. 3 HurstBS, StackhouseDJ, MathewsML, etal.UterinearteryembolizationforsymptomaticuterinemyomasJ.FertilSteril,2000, 74:855-869. 4 RavinaJH.Embolizationofuterinemyomata:methods, limitsandfutureC.C
4、hile:XIIFIGOWorldCongressofGynecologistandObstetrics, 2003. 5 RavinaJH, LedrefO.Arterialembolizationofuterinemyoma:resultsaproposof286casesJ.JGynecolObstetBiolReprod,2000, 29(3):272-275.6 MessinaML, BozziniN, HalbeHW, etal.Uterinearteryembo-lizationforthetreatmentofuterineleiomyomaJ.IntJGynae-colObs
5、tet, 2002, 79(1):11-16.7 BroderMS, GoodwinS, ChenG, etal.Comparisonoflong-termoutcomesofmyomectomyanduterinearteryembolizationJ.ObstetGynecol, 2002, 100(5Pt1):864-868.8 McLucasB, AdlerL, PerelaR.Uterinefibroidembolization:nonsurgicaltreatmentforsymptomaticfibroidsJ.JAmColSurg, 2001, 192:95-105.9 Edw
6、ardsRD, MossJG, LumsdenMA, etal.CommiteeoftherandomizedtrialofembolizationversussurgicalforsymptomaticuterinefibroidsJ.NEnglJMed, 2007, 356:360-370.10 DavidM, EbertAD.Treatmentofuterinefibroidsbyemboliza-tion-advantages,disadvantages, andpitfalsJ.EurJObstetGynecolReprodBiol, 2005;123:131-138.11 Park
7、erWH.Uterinemyomas:managementJ.FertilSteril,2007, inpress.12 GoldbergJ, PereiraL, BerghelaV.Pregnancyafteruterinear-teryembolizationJ.ObstetGynecol, 2002, 100:869-872.13 CarpenterTT, WalkerWJ.Pregnancyfolowinguterinearteryembolizationforsymptomaticfibroids:aseriesof26completedpregnanciesJ.BJOG, 2005
8、, 112:321-325.14 AhmadA, QadanL, HassanN, etal.Uterinearteryemboliza-tiontreatmentofuterinefibroids:efectonovarianfunctioninyoungerwomenJ.JVascIntervRadiol, 2002, 13(10):1017-1020.15 LockwoodCJ.Ifyourpatienthassymptomaticmyomas, isUAEanoption?J.ContemporaryOb/Gyn, 2007, April.9-11.(2007-10-20 l)cI|:
9、1005-2216(2008)01-0030-04o ?p%h Z王建六,张晓红1oM:盆底功能障碍性疾病;压力性尿失禁keywords:pelvicfloordysfunctionaldisease;stressurinaryincontinencems |:R71 DS :AT:v D S,1000440Q:o ?p%h(pelvicfloordysfunctionaldisease, PFD) M onh,?h q40%,1 8 2(stressurinaryincontinence,SUI)。 “ -1 %h, B S: S U o y S。S1POPSUI , 、4 Q T4,S=
10、S= U e(ICS)S= S U(IUGS)。S =1PFD ,?Z 。 2005 MD Ss S o F, z 7 ,. 4 Q,w ZE,X S5,i sh q2% 46%, 2002 M S U Z nr163a ,AiF3 q Bn。“ , A ( U)Z n9v,1/3。 S20 8 2h q18.1% 57.5%, or50%。y s u、ZEy Y, U 1、 Uhn,D nX3h、 F, or B5Kn %hB。7, “ -S,i M1/3。 C M #,1, U q。h , MA VC, Py, 。 AU g4E JD SD U M1 MC,6.6%D 37.4% V “
11、- uM o U h q30% ;$# 8# ;50.8%D 3 “ - j。yN,4D 3h M, ?B,4h 。yp SD 3 H, U 5,+Y ?C 8# 5# 3 Y。 6,V ! U S , MM1,1, U,t B) 1。 8 ?p10| G 、e。S=1 M1 ,7 M1 S K q5 (22.4%)6。 E i?,1/n :| f ; 1Z , ?|; ) T; E L,i|*;i ; 。3 “5 7 S, “ -S =%s8 , + VE S K? 3, 3 $8 r 4。9,v D (4 U | -C、 8ym zrT,.d T。 i?in,9。3.2 8y m (tot
12、alpelvicreconstruction) 8y m Ey - 8,r “。 m 1996 MUlmsten nQ | U f (tension-freevaginaltape,TVT) m ,TVTZEC U m |ABS, P P m VFL7 m rT t X。 2001 MDelorme 9 d,Oo U f (TVT-O),N m f d| U d = 。yTVT-O , , O?_, aSD = T, M S = m 1。N, 8s 381 。yN, x% =0 m g a,i j -L.&#_。2 -L. -L. Cs0 3/ A T/ M,YV* s%L.s ,|L.h M 8,V7rL.h8 (# 3,i (L.h4 4 m 。 x% =0 -L. V x% =0 8L.hB。“ - VYV -L./ yL.33S L S S2008 M124 1
